360 related articles for article (PubMed ID: 32960106)
1. Thrombo-inflammatory features predicting mortality in patients with COVID-19: The FAD-85 score.
Wang J; Zhang H; Qiao R; Ge Q; Zhang S; Zhao Z; Tian C; Ma Q; Shen N
J Int Med Res; 2020 Sep; 48(9):300060520955037. PubMed ID: 32960106
[TBL] [Abstract][Full Text] [Related]
2. COVID-19 coagulopathy: An in-depth analysis of the coagulation system.
Martín-Rojas RM; Pérez-Rus G; Delgado-Pinos VE; Domingo-González A; Regalado-Artamendi I; Alba-Urdiales N; Demelo-Rodríguez P; Monsalvo S; Rodríguez-Macías G; Ballesteros M; Osorio-Prendes S; Díez-Martín JL; Pascual Izquierdo C
Eur J Haematol; 2020 Dec; 105(6):741-750. PubMed ID: 32749010
[TBL] [Abstract][Full Text] [Related]
3. IP-10 and MCP-1 as biomarkers associated with disease severity of COVID-19.
Chen Y; Wang J; Liu C; Su L; Zhang D; Fan J; Yang Y; Xiao M; Xie J; Xu Y; Li Y; Zhang S
Mol Med; 2020 Oct; 26(1):97. PubMed ID: 33121429
[TBL] [Abstract][Full Text] [Related]
4. IL-6-based mortality risk model for hospitalized patients with COVID-19.
Laguna-Goya R; Utrero-Rico A; Talayero P; Lasa-Lazaro M; Ramirez-Fernandez A; Naranjo L; Segura-Tudela A; Cabrera-Marante O; Rodriguez de Frias E; Garcia-Garcia R; Fernández-Ruiz M; Aguado JM; Martinez-Lopez J; Lopez EA; Catalan M; Serrano A; Paz-Artal E
J Allergy Clin Immunol; 2020 Oct; 146(4):799-807.e9. PubMed ID: 32710975
[TBL] [Abstract][Full Text] [Related]
5. COVID-19 and SIC (!).
Nevzorov I; Tulamo R; Albäck A; Lassila R
J Vasc Surg; 2020 Sep; 72(3):1148-1150. PubMed ID: 32497749
[No Abstract] [Full Text] [Related]
6. Diagnostic performance of initial blood urea nitrogen combined with D-dimer levels for predicting in-hospital mortality in COVID-19 patients.
Cheng A; Hu L; Wang Y; Huang L; Zhao L; Zhang C; Liu X; Xu R; Liu F; Li J; Ye D; Wang T; Lv Y; Liu Q
Int J Antimicrob Agents; 2020 Sep; 56(3):106110. PubMed ID: 32712332
[TBL] [Abstract][Full Text] [Related]
7. COVID-19 and Hypercoagulability.
Sholzberg M
Clin Adv Hematol Oncol; 2020 Jul; 18(7):386-389. PubMed ID: 32903249
[No Abstract] [Full Text] [Related]
8. D-dimer levels on admission to predict in-hospital mortality in patients with Covid-19.
Zhang L; Yan X; Fan Q; Liu H; Liu X; Liu Z; Zhang Z
J Thromb Haemost; 2020 Jun; 18(6):1324-1329. PubMed ID: 32306492
[TBL] [Abstract][Full Text] [Related]
9. Coagulopathy in COVID-19: Focus on vascular thrombotic events.
Shi W; Lv J; Lin L
J Mol Cell Cardiol; 2020 Sep; 146():32-40. PubMed ID: 32681845
[TBL] [Abstract][Full Text] [Related]
10. Haematological characteristics and risk factors in the classification and prognosis evaluation of COVID-19: a retrospective cohort study.
Liao D; Zhou F; Luo L; Xu M; Wang H; Xia J; Gao Y; Cai L; Wang Z; Yin P; Wang Y; Tang L; Deng J; Mei H; Hu Y
Lancet Haematol; 2020 Sep; 7(9):e671-e678. PubMed ID: 32659214
[TBL] [Abstract][Full Text] [Related]
11. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia.
Tang N; Li D; Wang X; Sun Z
J Thromb Haemost; 2020 Apr; 18(4):844-847. PubMed ID: 32073213
[TBL] [Abstract][Full Text] [Related]
12. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy.
Tang N; Bai H; Chen X; Gong J; Li D; Sun Z
J Thromb Haemost; 2020 May; 18(5):1094-1099. PubMed ID: 32220112
[TBL] [Abstract][Full Text] [Related]
13. Venous Thromboembolism Complicated with COVID-19: What Do We Know So Far?
Tal S; Spectre G; Kornowski R; Perl L
Acta Haematol; 2020; 143(5):417-424. PubMed ID: 32396903
[TBL] [Abstract][Full Text] [Related]
14. COVID-19 in the Healthy Patient Population: Demographic and Clinical Phenotypic Characterization and Predictors of In-Hospital Outcomes.
Ronderos Botero DM; Omar AMS; Sun HK; Mantri N; Fortuzi K; Choi Y; Adrish M; Nicu M; Bella JN; Chilimuri S
Arterioscler Thromb Vasc Biol; 2020 Nov; 40(11):2764-2775. PubMed ID: 32907371
[TBL] [Abstract][Full Text] [Related]
15. Clinical characteristics and survival analysis in critical and non-critical patients with COVID-19 in Wuhan, China: a single-center retrospective case control study.
Tian R; Wu W; Wang C; Pang H; Zhang Z; Xu H; Luo Q; Gao P; Shi J; Li W; Qian H; Guo F; Li T; Liu Z; Wang J; Zhou X; Qin Y; Yan X; Zhang S
Sci Rep; 2020 Oct; 10(1):17524. PubMed ID: 33067568
[TBL] [Abstract][Full Text] [Related]
16. Thromboembolic events and apparent heparin resistance in patients infected with SARS-CoV-2.
Beun R; Kusadasi N; Sikma M; Westerink J; Huisman A
Int J Lab Hematol; 2020 Jun; 42 Suppl 1(Suppl 1):19-20. PubMed ID: 32311843
[No Abstract] [Full Text] [Related]
17. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.
Zhou F; Yu T; Du R; Fan G; Liu Y; Liu Z; Xiang J; Wang Y; Song B; Gu X; Guan L; Wei Y; Li H; Wu X; Xu J; Tu S; Zhang Y; Chen H; Cao B
Lancet; 2020 Mar; 395(10229):1054-1062. PubMed ID: 32171076
[TBL] [Abstract][Full Text] [Related]
18. Prominent coagulation disorder is closely related to inflammatory response and could be as a prognostic indicator for ICU patients with COVID-19.
Liu Y; Gao W; Guo W; Guo Y; Shi M; Dong G; Ge Q; Zhu J; Lu J
J Thromb Thrombolysis; 2020 Nov; 50(4):825-832. PubMed ID: 32761495
[TBL] [Abstract][Full Text] [Related]
19. Factors associated with death outcome in patients with severe coronavirus disease-19 (COVID-19): a case-control study.
Pan F; Yang L; Li Y; Liang B; Li L; Ye T; Li L; Liu D; Gui S; Hu Y; Zheng C
Int J Med Sci; 2020; 17(9):1281-1292. PubMed ID: 32547323
[No Abstract] [Full Text] [Related]
20. Determinants of COVID-19 disease severity in patients with underlying rheumatic disease.
Santos CS; Morales CM; Álvarez ED; Castro CÁ; Robles AL; Sandoval TP
Clin Rheumatol; 2020 Sep; 39(9):2789-2796. PubMed ID: 32720259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
